Breathe Well Live Well
Condition: Asthma
Interventions: Drug: Respimat® Budesonide low dose; Drug: Respimat® Budesonide high dose; Drug: Turbohaler® Budesonide; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
BRIEF-Vectura says in US collaboration agreement for VR506 asthma therapy
Reuters Announces a further US collaboration agreement with a leading international pharmaceutical company for VR506 asthma therapy. * Vectura's partner will be responsible for commercialisation and manufacture of product together with clinical development … |
View full post on asthma – Google News
|
Steroid-sparing therapy is promising for allergic asthma
Skin and Allergy News Digital Network KEYSTONE, COLO. – A novel toll-like receptor-9 agonist showed impressive clinical efficacy in persistent allergic asthma in a double-blind, placebo-controlled clinical trial. "This is really interesting," Dr. Harold S. Nelson commented in highlighting … |
View full post on asthma – Google News
Condition: Drug Allergy
Intervention: Drug: Omalizumab
Sponsors: Dana-Farber Cancer Institute; Novartis Pharmaceuticals
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Irish Independent |
Asthma experts hit out at 'salt cave' therapy
Irish Independent The Asthma Society of Ireland was responding to claims made by a Polish medical group that the underground caves had proven to be a "really effective" means of treatment and in some cases had actually cured people of asthma. The comments were made … |
View full post on asthma – Google News
|
Interferon therapy offers new hope for kids with asthma
Medical Xpress Using data from TICHR's 158-family,10 year Childhood Asthma Study, Dr Fear is following up what happened to babies who showed a high risk for asthma when they were born and what happened to babies who showed a low risk for asthma at birth. |
View full post on asthma – Google News
|
New study seeks to improve asthma therapy for African-Americans
CrossRoadsNews Emory University School of Medicine and Children's Healthcare of Atlanta are lead recruiters for The Best African American Response to Asthma Drugs study that seeks to improve asthma therapy for African-Americans. The multicenter trial will assess … |
View full post on asthma – Google News
|
NIH Study Seeks to Improve Asthma Therapy for African-Americans
eNews Park Forest Bethesda, Maryland–(ENEWSPF)–February 13, 2014. Researchers will enroll around 500 African-American children and adults who have asthma in a multi-center clinical trial to assess how they react to therapies and to explore the role of genetics in … |
View full post on asthma – Google News
|
NIH study seeks to improve asthma therapy for African-Americans
National Institutes of Health (press release) Researchers will enroll around 500 African-American children and adults who have asthma in a multi-center clinical trial to assess how they react to therapies and to explore the role of genetics in determining the response to asthma treatment. This new … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Indacaterol; Drug: Indacaterol and tiotropium
Sponsors: University of Dundee; Tenovus Scotland
Not yet recruiting – verified January 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days